蘑菇视频

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 8, 2023--Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics designed to modulate the tumor microenvironment to elicit a potent and durable anti-tumor response, today announced that company leadership will present ...

NEW YORK--(BUSINESS WIRE)--Nov 8, 2023--<a ...

BOSTON--(BUSINESS WIRE)--Nov 8, 2023--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, ...